Warfarin
Prophylaxis and treatment of venous thrombosis and pulmonary embolism, Prophylaxis and treatment of thromboembolic complications associated with atrial..., Reduction in risk of death, recurrent myocardial infarction, and thromboembolic events...
Boxed warning
- WARNING: BLEEDING RISK Warfarin sodium can cause major or fatal bleeding [see Warnings and Precautions ( 5.1 )] . Perform regular monitoring of INR in all treated patients [see Dosage and Administration ( 2.1 )] . Drugs, dietary changes, and other factors affect INR levels achieved with warfarin sodium therapy [see Drug Interactions ( 7 )] . Instruct patients about prevention measures to minimize risk of bleeding and to report signs and symptoms of bleeding [see Patient Counseling Information ( 17 )] . WARNING: ... (see full label)
High-alert medication
- Antithrombotic agents - warfarin (class)
Indications
- Prophylaxis and treatment of venous thrombosis and pulmonary embolism
- Prophylaxis and treatment of thromboembolic complications associated with atrial...
- Reduction in risk of death, recurrent myocardial infarction, and thromboembolic events...
Adult dosing
- initial dose: dose: 2; unit: mg; route: PO; interval: 2 to 5 mg once daily; fixed: true; labelExcerpt: If the patient’s CYP2C9 and VKORC1 genotypes are not known, the initial dose of warfarin sodium tablets is usually 2 to 5 mg once daily.
- maintenance dose: dose: 2; unit: mg; route: PO; interval: 2 to 10 mg once daily; fixed: true; labelExcerpt: Typical maintenance doses are 2 to 10 mg once daily.
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- The label does not provide specific hepatic dosage adjustments but notes that the elimination of warfarin is almost entirely by metabolism in the liver.
Contraindications
- Pregnancy (except mechanical heart valves)
- Hemorrhagic tendencies or blood dyscrasias
- Recent or contemplated CNS/eye surgery
- Active ulceration or overt bleeding
- Malignant hypertension
Clinical pearls
- Requires regular INR monitoring to maintain therapeutic range; INR target is typically 2.5 (range 2-3).
- Narrow therapeutic index; sensitive to dietary vitamin K changes and drug-drug interactions.
- Do not double dose if a dose is missed; take as soon as possible on the same day.
- Perform INR daily upon initiation until stable, then every 1 to 4 weeks.
Source and review
- DailyMed label (warfarin sodium), Set ID 21255cd5-3c2e-4574-9620-9347d14256b3, effective 2026-11-05. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties